Please login to the form below
Global Pricing Innovations and Partners4Access partner on market access
Will collaborate on orphan drug pricing and access solutions
Man Boobs campaign wins at D&AD Impact Awards
Takes home White Pencil in inaugural awards
for creative contribution to society
Novartis says migraine prevention drug clears phase III trial
Monthly
injection co-developed with Amgen could be launched in 2018
High Force Research launches STEM outreach programme
Appoints STEM coordinator to encourage students’ interest in the industry
Amgen takes aim at cardio diseases with Arrowhead RNAi deal
Licenses two
gene silencing programmes with up to $670m in the offing for the specialist
Novo Nordisk to cut 1,000 jobs as diabetes competition builds
Cites intensifying US market in particular for
move to reduce costs
Bayer and Merck take high-risk heart failure drug into phase III
Embarks on final
study of vericiguat despite it not meeting objectives in phase II trial
Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal
Option to acquire
the Austrian biotech after phase I trials remains open to Boehringer
China: Smoking prevalence greater in men while women kick habit
New study also finds the number of
cigarettes smoked daily has risen
The global scourge of counterfeit medicines
Pharmaceuticals are a prime target for organised crime
-
Fair to medallingGenerally competent at strategic planning, how can pharma transition from acceptable to exceptional to deliver gold standard performances?
-
Surviving BrexitHow UK biopharma must adapt to a changing landscape
-
NICE backs Bayer’s Eylea as first-line BRVO treatmentRecommends visual impairment therapy over current laser treatment
-
Shire gives up on Momenta-partnered Humira biosimilarWill fund programme for another 12 months while divesting ongoing activities to Momenta
-
Amgen's Kyprolis scarred by head-to-head duel with VelcadeFailed to show superior progression-free survival in first-line treatment trials
-
Grünenthal research consortium receives €1.5m EU grantWins funding for development of efficacy testing in neuropathic pain treatments
-
Novartis' Ilaris wins three new FDA approvalsImmunotherapeutic expands in rare Periodic Fever Syndrome conditions
-
Kite Pharma soars after positive CAR-T data in lymphomaLooks to become first marketed CAR-T drug as phase II results pave way for US filing
-
Pfizer decides against long-discussed break-upSays dividing its R&D and generics businesses would disrupt rather than create value
Latest appointments
-
Nouscom appoints COO and board membersDr Marina Udier Blagovic takes on newly-created role while three join board
-
Merck KGaA appoints chief strategy officerIsabel De Paoli will take up the role from 1 October
-
Iris Pauporté joins OSE ImmunotherapeuticsShe becomes clinical project director at the French biotech
-
Novimmune expands senior management teamDr Sven Zimmerman and Mylène Fleurant join the Swiss biotech
-
Durbin appoints US business development principalTodd Galles now takes up the role on a permanent basis
Featured jobs
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35,000 according to skills and experience
- Editor, Medical Communications, London
-
Competitive Salary
- Healthcare PR Innovator, London
-
Excellent Package
Adepto Consulting
- Senior Account Director, Healthcare Advertising
-
£65,000 - £75,000 according to skills and experience
- Healthcare Advertising Scientific Copywriter
-
Salary TBC
- Medical Writer, Healthcare Education Design & Development, L...
-
Competitive Salary
- Client Lead, Consumer Health & Wellness, South East UK
-
Excellent Package
- Deputy Managing Director, Medical Communications, South East UK
-
Excellent Package
- Account Director - Medical Communications
-
Great salary and benefits
- HONG KONG!!! Senior Medical Writer & Principal Medical Write...
-
HIGHLEY COMPETATIVE SALARY, BONUS & BENEFITS
- Director, Scientific Services
-
£80 – 100,000 or more according to skills and experience + benefits
Media Contacts (Recruitment Consu ...
- Principal Medical Writer
-
£48 - 58,000 according to skills and experience + benefits
Media Contacts (Recruitment Consu ...
Subscribe to our email news alerts
- Global Pricing Innovations and Partners4Access partner on market access
- Man Boobs campaign wins at D&AD Impact Awards
- Blog: Personality + creatives + sugar = an exciting branding project with the Young Dementia Network
- Novartis says migraine prevention drug clears phase III trial
- Amgen takes aim at cardio diseases with Arrowhead RNAi deal
- How merging firms can manage culture change
PMHub
Synergy Vision
Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...
Latest intelligence
- Blog: Personality + creatives + sugar = an exciting branding project with the Young Dementia Network
- Steve Hunt, Strategy Director for Ashfield Digital & Creative, recently had the opportunity to work on a really exciting and rewarding project with the Young Dementia Network, here he shares...
- How merging firms can manage culture change
- Addressing the potential problems and finding the solutions...
- How to access and engage with HCPs effectively
- HCP engagement requires the right mix of voice and content, plus knowledge of the channels to access, to reach the target audience...
Quick links
Infographics
